Evolution of the Average Target: Exelon Corporation

Evolution of the Target Price: Exelon Corporation

Changes in Analyst Recommendations: Exelon Corporation

c87507151b2.Kn_4Te3jPxEzJbxYNm5704MgS4wZY5HuCfDc5FoZQIg.GD6JIaPXeHoBQfgBTyAcpOVWKN0pANqkeba6sz5cK8xwG8AiqYJdYXhP6Q~385b3962d3e41d2c0c078f47194a05ab
21/08 Morgan Stanley Adjusts Price Target on Exelon to $53 From $55, Keeps Equalweight Rating MT
20/08 JPMorgan Adjusts Exelon Price Target to $47 From $50 MT
31/07 BMO Capital Adjusts Price Target on Exelon to $47 From $48, Maintains Market Perform Rating MT
30/07 The Fed Gets a Better Inflation Number Zonebourse
30/07 Jefferies Adjusts Price Target on Exelon to $49 From $50, Maintains Hold Rating MT
22/07 Morgan Stanley Adjusts Price Target on Exelon to $55 From $54, Maintains Equalweight Rating MT
24/06 Morgan Stanley Adjusts Price Target on Exelon to $54 From $52, Maintains Equalweight Rating MT
21/05 Morgan Stanley Adjusts Price Target on Exelon to $52 From $55, Maintains Equalweight Rating MT
15/05 JPMorgan Adjusts Price Target on Exelon to $49 From $53, Maintains Neutral Rating MT
15/05 TD Cowen Adjusts Price Target on Exelon to $49 From $51, Maintains Hold Rating MT
13/05 KeyBanc Adjusts Price Target on Exelon to $41 From $43, Maintains Underweight Rating MT
11/05 Evercore ISI Adjusts Price Target on Exelon to $57 From $58 MT
28/04 Morgan Stanley Adjusts Price Target on Exelon to $55 From $56, Maintains Equalweight Rating MT
23/04 BMO Capital Adjusts Exelon Price Target to $48 From $49, Maintains Market Perform Rating MT
21/04 Morgan Stanley Adjusts Price Target on Exelon to $55 From $56, Maintains Equalweight Rating MT
21/04 KeyBanc Adjusts Price Target on Exelon to $43 From $44, Maintains Underweight Rating MT
21/04 Exelon Seen Offsetting PECO Rate Case Withdrawal Impact Over Time, RBC Says MT
20/04 Wells Fargo Adjusts Price Target on Exelon to $50 From $53, Maintains Overweight Rating MT
20/04 RBC Lowers Price Target on Exelon to $48 From $51, Keeps Sector Perform Rating MT
20/04 Jefferies Downgrades Exelon to Hold From Buy, Adjusts Price Target to $50 From $55 MT
18/04 Exelon Shares Fall After Multiple Downgrades MT
17/04 Mizuho Downgrades Exelon to Neutral From Outperform, Adjusts Price Target to $48 From $51 MT
17/04 Barclays Downgrades Exelon to Equalweight From Overweight, Adjusts PT to $49 From $50 MT
17/04 BMO Capital Downgrades Exelon to Market Perform From Outperform, Adjusts PT to $49 From $52 MT
17/04 Analyst recommendations: Albemarle, Newmont Corp, Texas Instruments, The Clorox Company, Oxy… Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+11.17%
+34.11%
+18.4%
+4.31%
+14.08%
+13.21%
+20.09%
+13.87%
+16.53%
+8.73%
Average +15.45%
Weighted average by Cap. +17.99%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
43.97USD
Average target price
48.88USD
Spread / Average Target
+11.17%
High Price Target
58.00USD
Spread / Highest target
+31.91%
Low Price Target
41.00USD
Spread / Lowest Target
-6.75%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. EXC Stock
  4. Consensus Exelon Corporation